| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459563 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
The course of HRQOL of HNSCC patients during the first 2Â years after CRT is different for survivors compared to non-survivors and is associated with comorbidity and tumor subsite.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Irma M. Verdonck-de Leeuw, Laurien M. Buffart, Martijn W. Heymans, Derek H. Rietveld, Patricia Doornaert, Remco de Bree, Jan Buter, Neil K. Aaronson, Ben J. Slotman, C. René Leemans, Johannes A. Langendijk,